- ►chestpubs.org HR Büller, G Agnelli, RD Hull, TM Hyers, MH … - Chest, 2004 - chestjournal.chestpubs.org This chapter about antithrombotic therapy for venous thromboembolic disease is
part of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy:
Evidence Based Guidelines. Grade 1 recommendations are strong and indicate ... Cited by 920 - Related articles - BL Direct - All 9 versions
- ►chestpubs.org J Ansell, J Hirsh, E Hylek, A Jacobson, M … - Chest, 2008 - chestjournal.chestpubs.org This article concerning the pharmacokinetics and pharmacodynamics of vitamin K
antagonists (VKAs) is part of the American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines (8th Edition). It describes the ... Cited by 892 - Related articles - BL Direct - All 21 versions
- ►annals.org [PDF] LA Linkins, PT Choi, JD Douketis - Annals of internal medicine, 2003 - Am Coll Physicians Background: Clinicians should consider the clinical impact of
anticoagulant-related bleeding when deciding on the duration of anticoagulant
therapy in patients with venous thromboembolism. Purpose: To provide ... Cited by 208 - Related articles - BL Direct - All 5 versions
C Kearon, SR Kahn, G Agnelli, S Goldhaber, … - Chest, 2008 - Am Coll Chest Phys Page 1. DOI 10.1378/chest.08-0658 2008;133;454S-545S Chest Gary E. Raskob and
Anthony J. Comerota Clive Kearon, Susan R. Kahn, Giancarlo ... Cited by 211 - Related articles - All 16 versions
- ►ahajournals.org JL Anderson, BD Horne, SM Stevens, AS Grove … - Circulation, 2007 - Am Heart Assoc Methods and Results— Consenting patients (n=206) being initiated on warfarin
were randomized to pharmacogenetic-guided or standard dosing. Buccal swab DNA
was genotyped for CYP2C9 *2 and CYP2C9 *3 and VKORC1C1173T with a rapid ... Cited by 147 - Related articles - BL Direct - All 7 versions
RI Baker, PB Coughlin, AS Gallus, PL Harper … - Medical Journal of Australia, 2004 - mja.com.au Warfarin pharmacokinetics and pharmacodynamics Warfarin and other coumarin
anticoagulants act by inhibiting the synthesis of functional vitamin K-dependent
coagulation factors II, VII, IX and X.4 Anticoagulants have no direct ... Cited by 92 - Related articles - View as HTML - BL Direct - All 16 versions
- ►hematologylibrary.org EA Millican, PA Lenzini, PE Milligan, L … - Blood, 2007 - bloodjournal.hematologylibrary.org High variability in drug response and a narrow therapeutic index complicate
warfarin therapy initiation. No existing algorithm provides recommendations on
refining the initial warfarin dose based on genetic variables, clinical ... Cited by 86 - Related articles - BL Direct - All 7 versions
- Free from Publisher D Garcia, S Regan, M Crowther, RA Hughes, … - Chest, 2005 - chestjournal.chestpubs.org * From the Department of Medicine (Dr. Garcia), Division of General Internal
Medicine, University of New Mexico School of Medicine, Albuquerque, NM; the
Department of Medicine (Drs. Regan and Hughes), General Medicine Division, ... Cited by 55 - Related articles - All 7 versions
BCG Lai-San Tham, A Nafziger, JY Guo, LZ … - Clinical Pharmacology & Therapeutics, 2006 - nature.com Methods: We used 215 records of warfarin patients recruited into a CYP2C9/VKORC1
genotyping study to perform this analysis. Univariate analyses for individual
predictors, including age, weight, gender, serum albumin concentration, ... Cited by 55 - Related articles - All 3 versions
